A multicenter, randomized, double-blind, positive-controlled clinical trial to evaluate the efficacy and safety of Compound Yinhua Jiedu Granule in the treatment of influenza (wind-heat syndrome)

Clinical Study of Intratumoral Injection of CAR-T Cells in the Treatment of Advanced Liver Tumors

计划入组 10 人 · 首次发布于 2021 年 7 月 6 日

Bioequivalence Study of Vonoprazan From Topoprazan 20 mg Tablets (Hikma Pharma, Egypt) Versus Takecab 20 mg Tablets (Takeda Pharmaceutical Co. Ltd., Japan)

计划入组 29 人 · 首次发布于 2021 年 11 月 26 日

JTYM

YJM (Beijing Science Sun Pharmaceutical Co., Ltd.)

SL-818(Beijing SL Pharmaceutical Co., Ltd.)

Jiangsu Aosaikang Pharmaceutical Co., Ltd.

China

Beijing Tide Pharmaceutical Co., Ltd.

China

Beijing SL Pharmaceutical Co., Ltd.

China

Shield Therapeutics' ACCRUFeR Receives Marketing Approval in South Korea for Iron Deficiency Treatment

Shield Therapeutics Secures FDA Approval Extension for ACCRUFeR in Pediatric Patients, Eyes China Market Entry in Q1 2026

Shield Therapeutics Reports $30.4M H1 2026 Revenue, Advances ACCRUFeR® into Phase II PAH Trial in Japan